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DNA Cytophotometric Findings in Pheochromocytoma 
Barbara-Christina Padberg,* Esther Garbe,* Like Achilles,* Henning Dralle,* 
Max Bressel,* and Soren Schroder* 
Fifty adrenalectomy specimens containing normal (n = 3), hyperplastic (n =4), or neoplastic (n = 
43) medullary tissue were subjected lo quantitative measurements of DNA conlent. Ofthe 43 
pheochromocytomas, 16 were neoplasms inherited in the setting of multiple endocrine neoplasia type 
2A. Five of 27 sporadic pheochromocytomas followed a malignant clinical course. Follow-up data 
were available in 25 patients. In normal medulla and adrenomedullary hyperplasia, eilher diploid or 
euploidDNA distributions were found. In contrast, 87% (33 of 38) of the benign and all five maUgnant 
pheochromocytomas exhibited nondiploid or aneuploid DNA histograms. No differences in DNA 
content existed between sporadic and hereditary tumors. In contrast to earlier reports, in this study 
DNA cytophotometry was nol suitable to discriminate benign from malignant adrenomedullary 
tumors. In addition, DNA measurements appeared not lo be a useful tool to assess the prognosis ofan 
individual malignant pheochromocytoma. (Henry Ford Hosp Med J 1989:37:185-6) 
H istology fails to show substantial differences between clinically benign and malignant adrenomedullary tumors, 
and criteria indicative of invasion and malignancy are an unre-
liable guide to the future outcome of the case (1-3). The only 
absolute criterion for diagnosing a malignant pheochromocy-
toma is the presence of secondary tumor deposits in sites where 
chromaffin fissue is not found normally (1,4). 
Cytophotometric DNA measurements have been shown to be 
a useful auxiliary method in a variety of malignant tumors of 
different sites (5-8). DNA data on pheochromocytomas reported 
thus far are sparse (4,9-11). Since these reports show discrepant 
results regarding the diagnostic and prognostic value of this 
method, we perfonned DNA cytophotometry on 50 adrenalec-
tomy specimens belonging to different types of medullary 
disease. 
Material and Methods 
The 50 adrenalectomy specimens were gathered from the sur-
gical pathology files of different institutes and departments of 
pathology. For documentation of preoperative symptoms, 
clinical case histories were reviewed. Follow-up data for 25 pa-
tients were obtained for an average of 33 months (range I to 180 
months). 
For reclassification, the hematoxylin-eosin stained slides 
were used roufinely. For diagnosis of adrenomedullary hyper-
plasia, morphometrical analyses of total medullary volumes 
were performed as described elsewhere (12). In six nonfunction-
ing adrenal tumors, the diagnosis of pheochromocytoma de-
pended on the immunocytochemical demonstration of synap-
tophysin-positivity (13) and negativity forthe adrenocortical 
marker Dit (14), 
For cytophotometric detennination of DNA content, 6 p,m-
thick paraffin sections were stained by Schiff's reagent (15). Sin-
gle cell DNA measurements were performed in the scanning 
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mode on a LEITZ-MPV-cytophotometer based on a LEITZ-
Orthoplan microscope. The measuring spot was 2.54 ixm ,^ and 
the steps of the scanning process were 0.5 |xm wide. Absorption 
ofthe probes was determined at a wavelength of 560 ± 9.5 nm. 
Seventy cells were examined for each case. Data were processed 
on-line by a EUROCOS-computer using specially adapted com-
mercial software (LEtTZ, Hamburg, West Germany). Deter-
mination of diploid values was performed using normal adre-
nomedullary cells of the three control specimens; the mean ± 2 
standard deviations of their cellular DNA content was defined as 
diploid region. Interpretation of the data was perfonned using 
the evaluation scheme of Auer et al (5), classifying DNA dis-
tribufions into four different histogram types (types I through 
IV). 
Results 
Patients' ages at diagnosis ranged from 12 to 78 (mean 47) 
years. The male;female ratio was 1:0.96. 
The series of 50 adrenalectomy specimens included three nor-
mal controls, four cases of adrenomedullary hyperplasia, and 43 
pheochromocytomas. Of the 27 sporadic tumors, 22 cases 
lacked morphologic or clinical features of malignancy. In 15 of 
these patients, follow-up data were available, each showing no 
evidence of disease at the end of the observation period. Five 
sporadic pheochromocytomas followed a malignant clinical 
course. Three of these five patients died two to 13 months after 
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surgery; the remaining two still have distant metastases. Sixteen 
tumors were neoplasms inherited in the setting of multiple endo-
crine neoplasia type 2A. Four of these 12 patients had bilateral 
disease. 
Upon cytophotometry, the adrenal medulla of the three con-
trol specimens was characterized by single distinct modal DNA 
values in the diploid region of normal cells (type I). The same 
finding was obtained for one of the four cases of adrenomedul-
lary hyperplasia, with the remaining three cases exhibiting eu-
ploid type II histograms defined as having either a distinct modal 
value in the tetraploid or near-tetraploid region or showing two 
well defined peaks around the diploid and tetraploid regions. 
Two (9%) of the 22 benign sporadic pheochromocytomas also 
represented type II histograms. For ten lesions (45.5%), type t i l 
populations were demonstrated, defined as having two pieaks but 
differing from the type I I populations in that the histograms 
showed a sizable number of celts with DNA amounts similar to 
those of control celts in DNA synthesis. The positions of the two 
peaks, as a rule, deviated somewhat from the diploid and 
tetraploid values of normal populations. In ten cases (45.5%), 
type IV specimens were seen with a very pronounced and irreg-
ular aneuploidy, with DNA amounts per cell ranging from levels 
near 2c up to values beyond 6c or even 14c. Ofthe five clinically 
malignant pheochromocytomas, one showed type III and three 
exhibited type IV histograms. Among the 16 hereditary pheo-
chromocytomas, types I I , I I I , and IV histograms were found in 
three (19%), six (37%), and seven (44%) cases, respectively. 
DNA histograms thus did not show consistent differences 
when comparing sporadic to hereditary and benign to malignant 
pheochromocytomas. 
Discussion 
To our knowledge, four studies on the diagnostic and prog-
nostic value of DNA determinations in pheochromocytomas 
have been reported. In a cytophotometric investigation, Lewis 
(9) found benign behavior in each of 12 lesions of diploid DNA 
content, whereas distant metastases were demonstrated for each 
of three aneuploid pheochromocytomas. Lewis suggested that 
such measurements allow discrimination between metastasizing 
and benign pheochromocytomas. A similar conclusion was 
drawn by Hosaka et al (It) based on flow cytometric studies of 
62 pheochromocytomas using the technique of Hedley et al (16). 
Each ofthe 18 pafients with normal DNA histograms followed a 
benign clinical course, whereas eight of 26 patients classified as 
DNA tetraploid/polyploid and seven of 18 patients exhibiting 
DNA aneuploid peaks had evidence of malignancy; the dif-
ferences between these groups were statistically significant. 
DNA ploidy measurements thus seemed to provide useful prog-
nostic information, while a clear-cut discrimination of benign 
and malignant neoplasms was not possible by this method. 
Klein et at (10) estimated flow cytometric DNA determinations 
to be an accurate, objective means of identifying adrenal malig-
nancy. However, only one clinically benign euploid pheo-
chromocytoma was included in their study of four normal and 
seven neoplasfic adrenal tissues. 
At variance to these studies, Amberson et al (4) in recent flow 
cytometric investigations found aneuploidy to be a phenomenon 
frequently encountered in benign adrenal pheochromocytomas. 
Of 19 such tumors, only six were diploid and nine clearly exhib-
ited aneuploid DNA content. 
We found nondiploid DNA values in 38 (88%) of 43 pheo-
chromocytomas, 21 of which clearly exhibited pronounced 
aneuploidy. Clinically malignant behavior could be established 
in only five of these tumors. The remaining 33 nondiploid le-
sions lacked morphologic evidence of malignancy, and follow-
up studies in 20 disclosed an uneventful postoperative course. 
Based on our results, DNA measurements appear to supply 
neither diagnostic nor prognostic information. In addition, 
DNA data do not provide differentiation between sporadic and 
hereditary tumors. A continuing search is necessary to find 
other procedures which provide a clear discrimination of risk 
groups in pheochromocytoma patients. 
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